Testing effectiveness (Phase 2)Study completedNCT00285103What this trial is testingSPC2996 in Chronic Lymphocytic LeukaemiaWho this might be right forChronic Lymphocytic Leukemia Santaris Pharma A/S 46
Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03534323What this trial is testingDuvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RSWho this might be right forChronic Lymphocytic LeukemiaRichter Syndrome Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)WithdrawnNCT01754870What this trial is testingPhase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) University of Wisconsin, Madison
Early research (Phase 1)WithdrawnNCT05037669What this trial is testingProgrammed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWho this might be right forAcute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT00882076What this trial is testingClofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasWho this might be right forLeukemia Milton S. Hershey Medical Center 22
Early research (Phase 1)UnknownNCT01619761What this trial is testingNK Cells in Cord Blood TransplantationWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT01650727What this trial is testingDinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT00005580What this trial is testingBryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880What this trial is testingAgatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)WithdrawnNCT02677948What this trial is testingMulticenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Who this might be right forChronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic University of Michigan Rogel Cancer Center
Early research (Phase 1)Study completedNCT00019838What this trial is testingUCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07476378What this trial is testingEvaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40